Business Wire

AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip ® FLEX-Mini™ Device

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
Seeking Alpha

AtriCure Announces First Use of the AtriClip PRO-Mini® Device

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (ATRC) (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, ...
Nasdaq

AtriCure's Shares Likely to Benefit From New AtriClip Device Sales

AtriCure, Inc. ATRC recently announced the treatment of the first patient with the AtriClip FLEX-Mini device. The device recently received the FDA 510(k) clearance. The AtriClip FLEX-Mini, the ...
Morningstar

AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention

Largest cardiac surgery device trial ever with 6,500 patients enrolled, this landmark trial evaluates the stroke reduction benefit with AtriClip devices for the over one million cardiac surgery ...